After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Centessa Pharmaceuticals plc ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Centessa Pharmaceuticals plc ADR is $2.23B. A total of 0.75 million shares were traded on the day, compared to an average of 615.76K shares.
In the most recent transaction, Weinhoff Gregory M sold 11,742 shares of CNTA for 16.47 per share on Jan 27 ’25. After the transaction, the Chief Business Officer now owns 159,782 company shares. In a previous transaction on Jan 27 ’25, Weinhoff Gregory M bought 11,742 shares at 16.47 per share.
Among the insiders who sold shares, SAHA SAURABH disposed of 55,000 shares on Jan 21 ’25 at a per-share price of $15.77. This resulted in the Chief Executive Officer holding 429,398 shares of CNTA after the transaction. In another insider transaction, SAHA SAURABH bought 55,000 shares at $15.29 per share on Jan 21 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CNTA has a high of $18.97 and a low of $7.38.
As of this writing, CNTA has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.4.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CNTA’s latest balance sheet shows that the firm has $595.08M in Cash & Short Term Investments as of fiscal 2021. There were $75.70M in debt and $24.64M in liabilities at the time. Its Book Value Per Share was $3.79, while its Total Shareholder’s Equity was $491.55M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CNTA is Buy with a score of 5.00.
